Complete Genomics, the Mountain View, CA-based company with a goal of sequencing full human genomes for $5,000, is announcing today that it has completed 14 full human genome sequences for commercial customers like March. The company says it has a dozen customers, including Pfizer, Duke University, the Institute for Systems Biology in Seattle, and the Broad Institute of MIT and Harvard. Last month, we reported on how Kirkland, WA-based OVP Venture Partners joined a syndicate that invested $45 million in Complete Genomics.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
